Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Boeing Signals Progress on Delayed 777X Program With Planned April First Flight 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
NEW YORK, May 16, 2017 -- Progyny, the leading fertility benefits company, today announced that it was named #13 on CNBC’s fifth annual Disruptor 50 List. The rapidly growing company secured its spot alongside companies such as Airbnb, Lyft, and WeWork.
The Disruptor 50 is an annual list of private companies that are shaking up the landscape and threatening the status quo in their respective industries. CNBC selects companies from a list of hundreds nominated by venture capitalists, industry analysts, and beat reporters. Disruptor 50 companies are widely regarded as poised for substantial growth.
Progyny’s employer offering is a cutting-edge women’s health benefit that supports fertility preservation and comprehensive family building. The program includes fertility benefits, such as IVF and egg freezing, and also support for individuals needing to build their families through surrogacy and adoption. Progyny’s fertility benefits combine service, science and data to optimize the clinical outcomes of fertility treatments, including increased IVF success, reduced time to pregnancy, and a reduced rate of multiples (twins), which is often a key driver of high-risk obstetric and NICU costs. Employer’s utilizing Progyny’s programs promote a workplace culture of supporting women and families. Progyny’s vision is to ensure that anyone who wants to have a child, can have one.
“Today is a proud day for Progyny. For the past year and a half, Progyny’s business has grown rapidly as more and more large employers are looking to adopt fertility benefits in order to attract and retain top talent, show appreciation for their female workforce, and highlight the importance of family building as a core value for their organizations,” said David Schlanger, Progyny CEO. “This accolade from CNBC further substantiates the interest in the fertility industry as a whole and our unique way of helping employees navigate this often opaque yet important benefit.”
For more information visit, www.Progyny.com. For the full list of CNBC Disruptor 50 companies, please visit the CNBC website.
About Progyny:
Progyny is a leading fertility benefits company that combines service, science, technology and data to provide comprehensive value based fertility solutions for self-insured employers. Progyny’s benefit plans are designed to improve outcomes, shorten time to pregnancy and reduce total fertility-related costs. Progyny is privately held and is headquartered in New York, NY, with operations in San Francisco, CA. Please visit www.progyny.com.
Media Contact: Heather Aponte [email protected] Phone: 646-965-0695
